Helmut Wolfgang Jeggle
CIK: 0001982614
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Jeggle Helmut Wolfgang
Jeggle Helmut Wolfgang (SEC CIK 0001982614) files insider reports with the SEC as Director of Bambusa Therapeutics, Inc. (BBTX) and Director of BioNTech SE (BNTX).
Signal8 holds 3 ownership filings by Jeggle Helmut Wolfgang (2 Form 3, 1 Form 4), filed between Mar 18, 2026 and Nov 2, 2026. Those filings report 2 transactions, the latest on Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jeggle Helmut Wolfgang's filings is in BOSTON, MA.
Recent filings by Jeggle Helmut Wolfgang
Other insiders filing for Bambusa Therapeutics, Inc. (BBTX)
- Salvia Investment GmbH, 10% Owner
- Xu Shanshan
- RA CAPITAL MANAGEMENT, L.P., Director
- Liang Howard, Director
- DiRocco Derek, Director
- Foerster Christian Uwe, Director